Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Connexin 43 in ischemic pre- and postconditioning.

Rainer Schulz1, Kerstin Boengler, Andreas Totzeck

  • 1Institut für Pathophysiologie, Zentrum für Innere Medizin, Universitätsklinikum Essen, Hufelandstrasse 55, 45122 Essen, Germany.

Heart Failure Reviews
|May 23, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early versus late add-on therapy in generalized myasthenia gravis: a multicenter real-world cohort study.

Journal of neurology·2026
Same author

Extracellular RNA drives TNF-α/TNF-receptor-1 mediated cardiac ischemia/reperfusion injury: Mechanistic insights and therapeutic potential of RNase1.

Pharmacological research·2025
Same author

Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen - a multicenter observational study.

Orphanet journal of rare diseases·2025
Same author

C5 complement inhibition versus FcRn modulation in generalised myasthenia gravis.

Journal of neurology, neurosurgery, and psychiatry·2025
Same author

Iatrogenic botulism after intragastric botulinum neurotoxin injections - a major outbreak.

Neurological research and practice·2024
Same author

Guideline-recommended basic parameter adherence in neurocritical care stroke patients: Observational multicenter individual participant data analysis.

European stroke journal·2024
Same journal

Mavacamten in adolescent obstructive hypertrophic cardiomyopathy: SCOUTing a way forward.

Heart failure reviews·2026
Same journal

Overcoming barriers to early diagnosis and treatment of p.Val142Ile amyloid transthyretin (ATTR) cardiomyopathy.

Heart failure reviews·2026
Same journal

Beyond vasodilation: sotatercept and the remodeling hypothesis in hfpef-associated pulmonary hypertension.

Heart failure reviews·2026
Same journal

Beyond the right ventricle: left heart involvement in pulmonary arterial hypertension.

Heart failure reviews·2026
Same journal

Left ventricular non-compaction in heart failure: contemporary perspective on diagnostic challenges and treatment opportunities.

Heart failure reviews·2026
Same journal

Correction to: Left atrial shunting devices: why, what, how, and… when?

Heart failure reviews·2026
See all related articles

Connexin 43 (Cx43) in mitochondria is crucial for ischemic preconditioning

Area of Science:

  • Cardiovascular Science
  • Mitochondrial Biology
  • Cellular Signaling

Background:

  • Connexin 43 (Cx43) forms gap junctions and hemichannels in the heart.
  • Cx43 is also found in cardiomyocyte mitochondria, influencing reactive oxygen species (ROS) production.
  • ROS are key in the protective signaling of ischemic preconditioning.

Purpose of the Study:

  • To investigate the role of mitochondrial Cx43 in cardioprotection.
  • To determine Cx43's involvement in ischemic preconditioning and postconditioning.

Main Methods:

  • Examined Cx43 localization in cardiomyocyte mitochondria.
  • Assessed the impact of genetic Cx43 loss and mitochondrial import inhibition on infarct size.
  • Compared Cx43's role in ischemic preconditioning versus postconditioning.

Related Experiment Videos

Main Results:

  • Loss of Cx43 abolished infarct size reduction by ischemic preconditioning.
  • Mitochondrial import inhibition of Cx43 blocked protection from pharmacological preconditioning.
  • Cx43 was not essential for infarct size reduction by ischemic postconditioning.

Conclusions:

  • Mitochondrial Cx43 is a key component in the signaling pathway for preconditioning-induced cardioprotection.
  • Cx43's role in cardioprotection is specific to preconditioning, not postconditioning.